|
Kala-azar
elimination in Bangladesh, India and Nepal
|
|
|
 Eliminating kala-azar in Member countries of the
WHO South-East Asia Region is relevant for achieving the Millennium
Development Goals (MDGs). Kala-azar is present in 109 districts in Bangladesh, India
and Nepal
and the target for elimination is less than 1 case per 10 000 population at
the district level by 2015. The disease affects primarily the poor, and
aggravates poverty. Elimination of the disease will help in the mitigation
of poverty in the affected areas, and contribute to achieving MDG 1 which
is to eradicate extreme poverty and hunger.
More Info… Link to
Communicable Disease Newsletter [PDF 844 KB]
|
|
H.E.
the President of Nepal lends support to the Regional Technical Advisory
Group for Kala-azar elimination
|
|
 WHO/SEARO
organized the fourth Regional Technical Advisory Committee (RTAG) for
Kala-azar elimination meeting on 10-12 July 2011 at Kathmandu, Nepal.
The meeting was attended by members of the RTAG and two scientists each
from WHO HQ and TDR, Geneva.
The WHO Nepal Country Office was also represented in this meeting. The RTAG
members had the proud privilege of meeting His Excellency the President of
Nepal Dr Ram Baran Yadav and spent approximately 45 minutes discussing key
issues on Kala-azar Elimination. The President expressed keen interest and
reiterated his government’s commitment to eliminate this dreaded disease.
More Info…
|
|
Member countries
agree to accelerate kala azar elimination activities
 At a
meeting organized by WHO Regional Office for South-East Asia, the Programme
Managers from kala azar endemic countries in South-East Asia Region agreed
to accelerate activities to eliminate kala-azar from Bangladesh, India
and Nepal
by 2015.
Recommendations
[PDF 17 KB]
|
|
UPDATE ON THE
STATUS OF VISCERAL LEISHMANIASIS (KALA AZAR)IN THE SEA REGION
 The
situation is worsening due to asymptomatic cases, PKDL, undernutrition
and kala-azar/HIV co-infections However, the
mortality is stable because of improved case management in the recent years
due to availability of better diagnostic tools (K39 kits) and oral drug miltofosine.
More info…
|
|
The Progress of
Implementation in Bangladesh
 In Bangladesh,
a national steering committee and a technical task force has been
established. Miltefosine is registered and
linkages have been developed between medical colleges, IEDCR and NIPSOM.
The pilot district selected is Mymensingh. The
elimination of kala-azar is being implemented in Trishal
upazila as a part of an operational research
effort in collaboration with TDR and other partners. Disease burden
studies, mapping of the disease and entomological spot checks have been
carried as preparatory activities. Miltefosine
and ‘rk39’ will be used in the upazila. Training
modules are being reviewed…
More info…
|
|
Memorandum of
article signed for Kala-azar
 The Health Ministers of three Member
States of WHO’s South-East Asia Region, India, Nepal
and Bangladesh
signed on 18 May 2005 a Memorandum of Understanding pledging to collaborate
to eliminate Visceral Leishmaniasis (Kala-azar) from their countries.
|
|
|
